3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow elbasvir: new trials by email Literature Review of elbasvir trials Research Report on elbasvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050) Grazoprevir, Elbasvir - Chronic Hepatitis C, Renal Impairment | Phase 1 | Completed | Merck Sharp & Dohme LLC | 24 | 2013-09-06 | 2019-06-12 |
| The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009) Elbasvir - Hepatic Insufficiency | Phase 1 | Completed | Merck Sharp & Dohme LLC | 31 | 2013-03-06 | 2018-10-25 |
| Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) Elbasvir, Placebo - Hepatitis, Viral, Human | Phase 1 | Completed | Merck Sharp & Dohme LLC | 48 | 2012-02-16 | 2018-07-17 |
Hepatic Insufficiency (1) · Hepatitis C, Chronic (1) · Hepatitis, Viral, Human (1) · Renal Insufficiency (1)
United States (1)